Trial intelligence / Profile preview

RECOVER: ADRCs for Hamstring Tears

NCT02045888Phase 2Withdrawn

Sponsor
Plus Therapeutics
Start
Jan 2014
Primary completion
Nov 2014
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Cytori Cell Therapy in Hamstring Injury, sponsored by Plus Therapeutics. Planned start Jan 2014; status: withdrawn.

02

Drugs

Cytori Cell Therapy
03

Conditions

Hamstring Injury

Beyond the preview

Go deeper on NCT02045888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02045888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call